Lawrence Cameron William 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed Feb 24, 2011
Insider Transaction Report
Form 4
Lawrence Cameron William
Principal Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2011-02-22$3.00/sh+1,400$4,200→ 4,450 total(indirect: RRSP) - Exercise/Conversion
Stock Option (right to buy)
2011-02-22−1,875→ 3,750 totalExercise: $3.00Exp: 2015-12-31→ Common (1,875 underlying) - Exercise/Conversion
Common Stock
2011-02-22$3.00/sh+475$1,425→ 950 total(indirect: By Spouse)
Footnotes (1)
- [F1]1,875 shares are exercisable on each of December 31, 2009, 2010, 2011 and 2012.